1ª prorroga Suministro de FIBRINÓGENO HUMANO Y COMPLEJO PROTOMBINICO 500 UI PARENTERAL para el Servicio de farmacia del Hospital Clínico San Carlos de Madrid.
Awarded
The competition has ended and a winner has been selected.
- Deadline
- Feb 17,Expired
- Award
- Quality, weight 30
Brief
El HOSPITAL CLINICO SAN CARLOS ha adjudicado un acuerdo marco a OCTAPHARMA, S.A., CSL BEHRING, S.A., TAKEDA FARMACEUTICA ESPAÑA, S.A. y LFB BIOTERAPIAS HISPANIA, S.L. para el suministro de FIBRINÓGENO HUMANO Y COMPLEJO PROTROMBÍNICO 500 UI PARENTERAL para el Servicio de Farmacia del Hospital Clínico San Carlos de Madrid. El contrato tiene una duración de 1 año y un valor máximo total de 1.772.480 EUR. Se recibieron 3 ofertas para esta adjudicación.
Farmasøytisk engroshandel
Result
- CSL BEHRING, S.A.Winner
- LFB Bioterapias Hispania, S.L.Winner
- Octapharma, S.A.Winner
- TAKEDA FARMACEUTICA ESPAÑA, S.A.Winner
- 3Number of tenders received
- Not statedContract value
- Maximum framework agreement valueUp to €1,602,860
Previous winners
Who are you up against?
The suppliers who have won similar contracts at HOSPITAL CLINICO SAN CARLOS DE MADRID
Will you bid?
The agent sets up the bid and writes the first draft. Free for 14 days.
Award Criteria
Description
70 puntos
Source
No source found in the documents. Check the weight against the tender documents.
Description
30 puntos
Source
No source found in the documents. Check the weight against the tender documents.
From the notice
1ª prorroga Suministro de FIBRINÓGENO HUMANO Y COMPLEJO PROTOMBINICO 500 UI PARENTERAL para el Servicio de farmacia del Hospital Clínico San Carlos de Madrid.
Contact
Hospital Clínico San Carloscontratacionadva.hcsc@salud.madrid.org- Result · Framework agreementType
- MadridLocation
- 33600000Main codePharmaceutical products